A carregar...
PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance
The development of nanomaterials to induce antigen-specific immune tolerance has shown promise for treating autoimmune diseases. While PEGylation has been widely used to reduce host immune responses to nanomaterials, its tolerogenic potential has not been reported. Here, we report for the first time...
Na minha lista:
| Publicado no: | J Control Release |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968989/ https://ncbi.nlm.nih.gov/pubmed/33450320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2021.01.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|